Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35491970)

  • 1. A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.
    Yang L; Fan X; Qin W; Xu Y; Zou B; Fan B; Wang S; Dong T; Wang L
    Cancer Med; 2022 Nov; 11(22):4246-4255. PubMed ID: 35491970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
    She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
    JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Deep Learning-Based Prediction Model for the Prognosis of Operable Cervical Cancer.
    Dong T; Wang L; Li R; Liu Q; Xu Y; Wei Y; Jiao X; Li X; Zhang Y; Zhang Y; Song K; Yang X; Cui B
    Comput Math Methods Med; 2022; 2022():4364663. PubMed ID: 36471752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC.
    Jin L; Zhao Q; Fu S; Cao F; Hou B; Ma J
    Front Oncol; 2023; 13():1092478. PubMed ID: 36994203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
    Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
    Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy.
    Astley JR; Reilly JM; Robinson S; Wild JM; Hatton MQ; Tahir BA
    Radiother Oncol; 2024 Apr; 193():110084. PubMed ID: 38244779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
    Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
    PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
    Finkle JH; Penney BC; Pu Y
    Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
    Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
    JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study.
    Zhang S; Liu X; Zhou L; Wang K; Shao J; Shi J; Wang X; Mu J; Gao T; Jiang Z; Chen K; Wang C; Wang G
    EClinicalMedicine; 2023 Nov; 65():102270. PubMed ID: 38106558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning model integrating positron emission tomography and clinical data for prognosis prediction in non-small cell lung cancer patients.
    Oh S; Kang SR; Oh IJ; Kim MS
    BMC Bioinformatics; 2023 Feb; 24(1):39. PubMed ID: 36747153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
    Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of socioeconomic status on cancer staging, survival in non-small cell lung cancer.
    Yang X; Deng L; Li M; Zhou Y; Wang G
    Front Public Health; 2022; 10():992944. PubMed ID: 36424960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
    Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
    Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer.
    Cai JS; Dou XM; Li JB; Yang MZ; Xie CL; Hou X; Yang HX
    Semin Thorac Cardiovasc Surg; 2022; 34(3):1040-1048. PubMed ID: 34216749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.